Amwell(AMWL)
Search documents
Amwell(AMWL) - 2023 Q4 - Earnings Call Transcript
2024-02-15 02:05
American Well Corporation (NYSE:AMWL) Q4 2023 Earnings Conference Call February 14, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Bob Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jack Wallace - Guggenheim Securities Charles Rhyee - TD Cowen Eduardo Ron - Truist Securities Eric Percher - Nephron Research Jessica Tassan - Piper Sandler Stan Berenshteyn - Wells Fargo Securit ...
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research· 2024-02-14 23:51
American Well Corporation (AMWL) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 10.53%. A quarter ago, it was expected that this company would post a loss of $0.20 per share when it actually produced a loss of $0.20, delivering no surprise.Over the last four quarters, the company has surpass ...
Amwell Announces Results for Fourth Quarter and Full Year 2023
Newsfilter· 2024-02-14 21:05
Boston, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leader in hybrid care enablement, today announced financial results for the fourth quarter and full year ended Dec. 31, 2023. Amwell is a small-cap growth company and a leading provider of healthcare software as a service. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2023 earnings report. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET, Wedne ...
Amwell(AMWL) - 2023 Q4 - Annual Report
2024-02-14 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39515 | --- | --- | |---------------------------------------------------------------------------------------------------------------- ...
Amwell to Report Fourth Quarter and Full Year 2023 Operating Results on Feb. 14
Newsfilter· 2024-01-31 11:00
Boston, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital healthcare enablement, will report its fourth quarter 2023 operating results on Wednesday, Feb. 14. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the Investors section of the company's websit ...
Amwell(AMWL) - 2023 Q3 - Earnings Call Transcript
2023-11-02 02:09
American Well Corporation (NYSE:AMWL) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Sue Dooley - Head-Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Bob Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Stan Bernstein - Wells Fargo Securities Jailendra Singh - Truist Securities Jack Wallace - Guggenheim Securities Matt Shea - Needham & Company Charles Rhyee - TD Cowen Glen Santangelo - Jefferies Dav ...
Amwell(AMWL) - 2023 Q3 - Quarterly Report
2023-10-31 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39515 American Well Corporation (Exact name of registrant as specified in its charter) Delaware 20-5009396 (State of incorpora ...
Amwell(AMWL) - 2023 Q2 - Earnings Call Transcript
2023-08-03 02:06
American Well Corporation (NYSE:AMWL) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Sue Dooley - Head of IR Ido Schoenberg - Chairman and CEO Bob Shepardson - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Jack Wallace - Guggenheim Securities Stan Bernstein - Wells Fargo Securities Glen Santangelo - Jefferies Charles Rhyee - TD Cowen Alan Lutz - Bank of America Merrill Lynch Operator Good afternoon. My name is David and I'll be your conference operator t ...
Amwell(AMWL) - 2023 Q2 - Quarterly Report
2023-08-01 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39515 American Well Corporation (Exact name of registrant as specified in its charter) Delaware 20-5009396 (State of incorporation) ...
American Well Corporation (AMWL) Investor Presentation - Slideshow
2023-05-18 18:09
Investor Presentation Forward Looking Statement This presentation contains forward-looking statements about us and our industry that involve substantial risks and uncertaintiesand are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in these comments, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future opera ...